Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism

被引:0
作者
Hulya Taskapan
Reinhold Vieth
Dimitrios G. Oreopoulos
机构
[1] University of Toronto,Division of Nephrology
[2] University of Toronto,Department of Nutritional Sciences
[3] University of Toronto,Department of Laboratory Medicine and Pathobiology
来源
International Urology and Nephrology | 2008年 / 40卷
关键词
Vitamin D intoxication; Parathyroid hormone; 24 Hydroxylase;
D O I
暂无
中图分类号
学科分类号
摘要
A 77-year-old woman had taken 50,000 IU of vitamin D2 daily, instead of once weekly, for over 2 years. She developed severe hypercalcemia, and after stopping vitamin D, her serum 25-hydroxyvitamin D (25(OH)D) remained higher than 250 nmol/l for almost 2½ years. Inappropriately high parathyroid (PTH) concentrations were particularly evident after serum calcium was suppressed to slightly above the reference range by the administration of intravenous pamidronate and prednisone. It seems that an underlying primary hyperparathyroidism that was masked initially by the hypercalcemia of vitamin D intoxication was responsible for the unusually prolonged half-life of 25(OH)D in the blood. After vitamin D2 had been stopped, the decline in serum 25(OH)D was unusually slow. In this unusual case, primary hyperparathyroidism probably prevented an appropriate increase in the vitamin D-catabolizing enzyme, 25(OH)D-24-hydroxylase, thereby slowing metabolic clearance of 25(OH) vitamin D.
引用
收藏
页码:801 / 805
页数:4
相关论文
共 50 条
  • [41] Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives
    Drueeke, Tilman B.
    Ritz, Eberhard
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01): : 234 - 241
  • [42] Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care
    Hin, H.
    Tomson, J.
    Newman, C.
    Kurien, R.
    Lay, M.
    Cox, J.
    Sayer, J.
    Hill, M.
    Emberson, J.
    Armitage, J.
    Clarke, R.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (03) : 841 - 851
  • [43] Vitamin D intoxication and therapy with alendronate (case report and review of literature)
    Zerrin Orbak
    Hakan Doneray
    Filiz Keskin
    Ahmet Turgut
    Handan Alp
    Cahit Karakelleoglu
    European Journal of Pediatrics, 2006, 165 : 583 - 584
  • [44] A rare cause of kidney injury: vitamin D3 intoxication
    David, Hutkai
    Miklos, Bodor
    ORVOSI HETILAP, 2023, 164 (47) : 1871 - 1876
  • [45] HYPERCALCEMIA AND HYPEROSTEOLYSIS IN VITAMIN-D INTOXICATION - EFFECTS OF CLODRONATE THERAPY
    RIZZOLI, R
    STOERMANN, C
    AMMANN, P
    BONJOUR, JP
    BONE, 1994, 15 (02) : 193 - 198
  • [46] Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis
    Atabek, ME
    Pirgon, O
    Sert, A
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (02) : 169 - 172
  • [47] Vitamin D and its role in skeletal muscle
    Ceglia, Lisa
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2009, 12 (06) : 628 - 633
  • [48] The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
    Zittermann, Armin
    Gummert, Jan F.
    Boergermann, Jochen
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (09) : 933 - 942
  • [49] Vitamin D and Its Role in Skeletal Muscle
    Ceglia, Lisa
    Harris, Susan S.
    CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (02) : 151 - 162
  • [50] Vitamin D role in arterial hypertension development
    Dudinskaya, E. N.
    Tkacheva, O. N.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (03): : 77 - 81